Susceptibility to Salmonella typhimurium infection and effectiveness of vaccination in mice deficient in the tumor necrosis factor alpha p55 receptor

Infection and Immunity

Volumn 66, Issue 7, 1998, Pages 3355-3364

  Everest, Paul ^a   Roberts, Mark ^a,b   Dougan, Gordon ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P55; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BACTERIAL VIRULENCE; CELL PROLIFERATION; INFECTION SENSITIVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SALMONELLA TYPHIMURIUM; SALMONELLOSIS; SPLEEN CELL; VACCINATION;

EID: 0031841730     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.66.7.3355-3364.1998     Document Type: Article

References (41)

1. Bancroft, G. J., K. C. F. Sheehan, R. D. Schreiber, and E. Unanue. 1989. Tumour necrosis factor is involved in the T-cell independent pathway of macrophage activation in SCID mice. J. Immunol. 143:127-132.
2. Bermudez, L. E. M., and L. S. Young. 1988. Tumour necrosis factor alone or in combination with IL-2, but not IFN-γ, is associated with macrophage killing of Mycobacterium avium complex. J. Immunol. 140:3006-3013.
3. Blackwell, J. M. 1988. Bacterial infections, p. 63-98. In D. M. Wakelin and J. M. Blackwell (ed.), Genetics of resistance to bacterial and parasitic infections. Taylor and Francis, London, United Kingdom.
4. Collins, F. M., G. B. Mackaness, and R. V. Blanden. 1966. Infection and immunity in experimental salmonellosis. J. Exp. Med. 124:601-619.
5. Collins, F. M. 1974. Vaccines and cell-mediated immunity. Bacteriol. Rev. 38:371-402.
6. Dougan, G. 1994. Genetics as a route toward mucosal vaccine development, p. 491-506. In V. L. Miller, J. B. Kaper, D. A. Portnoy, and R. R. Isberg (ed.), Molecular genetics of bacterial pathogenesis. ASM Press, Washington, D.C.
7. Eisenstein, T. K., L. Killar, and B. M. Sultzer. 1985. Immunity and infection in Salmonella typhimurium: mouse-strain differences in vaccine and serum induced protection. J. Infect. Dis. 150:425-435.
8. Finlay, B. B. 1994. Molecular and cellular mechanisms of Salmonella pathogenesis. Curr. Top. Microbiol. 192:163-185.
9. Flynn, J. L., M. M. Goldstein, J. Chan, K. J. Triebold, K. Pfeffer, C. J. Lowenstein, R. Schreiber, T. W. Mak, and B. B. Bloom. 1995. Tumour necrosis factor α is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 2:561-566.
10. Green, S. J., C. A. Nacy, R. D. Schreiber, D. L. Granger, R. M. Crawford, M. S. Meltzer, and A. H. Fortier. 1991. Neutralization of gamma interferon and tumor necrosis factor alpha blocks in vivo synthesis of nitrogen oxides from L-arginine and protection against Francisella tularensis infection in Mycobacterium bovis BCG-treatcd mice. Infect. Immun. 61:689-698.
11. Green, S. J., and C. A. Nacy. 1993. Antimicrobial and immunopathologic effects of cytokine-induced nitric oxide synthesis. Curr. Opin. Infect. Dis. 6: 384-396.
12. Havell, E. A. 1987. Production of tumour necrosis factor during murine listeriosis. J. Immunol. 139:4225-4231.
13. Havell, E. A. 1989. Evidence that tumour necrosis factor has an important role in antibacterial resistance. J. Immunol. 143:2894-2899.
14. Hess, J., C. Ladel, D. Miko, and S. H. Kaufmann. 1996. Salmonella typhimurium aroA- infection in gene targeltcd immunodeficient mice: major role of CD4+ TCR-alpha beta cells and IFN-gamma in bacterial clearance independent of intracellular location. J. Immunol. 156:3321-3326.
15. Hook, E. W. 1985. Salmonella species (including typhoid fever), p. 1256-1266. In G. L. Mandell, R. G. Douglas, and J. E. Bennett (ed.), Principles and practice of infectious diseases, Churchill Livingstone, New York, N.Y.
16. Hormaeche, C. E. 1979. Natural resistance to Salmonella typhimurium in different inbred mouse strains. Immunology 37:311-318.
17. Hormaeche, C. E., P. Mastroeni, A. Arena, J. Uddin, and H. S. Joysey. 1990. T-cells do not mediate the initial suppression of a Salmonella infection in the R. E. S. Immunology 70:247-250.
18. Hornick, R. B., S. E. Greisman, T. E. Woodward, H. L. DuPont, A. T. Dawkins, and M. J. Snyder. 1970. Typhoid fever: pathogenesis and control. N. Engl. J. Med. 283:686-691.
19. Hornick, R. B., S. E. Greisman, T. E. Woodward, H. L. DuPont, A. T. Dawkins, and M. J. Snyder. 1970. Typhoid fever: pathogenesis and control. N. Engl. J. Med. 283:739-746.
20. Kaufmann, S. H. E. 1993. Immunity to intracellular bacteria. Annu. Rev. Immunol. 11:129-163.
21. Kaufmann, S. H. E. 1994. Bacterial and protozoal infections in genetically disrupted mice. Curr. Opin. Immunol. 6:518-525.
22. Mastroeni, P., A. Arena, G. B. Costa, M. C. Liberto, L. Bonina, and C. E. Hormaeche. 1991. Serum TNF in mouse typhoid and enhancement of the infection by anti-TNF antibodies. Microb. Pathog. 11:33-38.
23. Mastroeni, P., B. Villareal, and C. E. Hormaeche. 1992. Role of T-cells, TNF and IFN in recall of immunity to oral challenge with virulent salmonellae in mice vaccinated with live attenuated am Salmonella vaccines. Microb. Pathog. 13:477-491.
24. Muotiala, A., and P. H. Makela. 1990. The role of IFN in murine Salmonella typhimurium infection. Microb. Pathog. 8:135-141.
25. Nauciel, C., F. Espinasse-Maes, and P. Matsiota-Bernad. 1992. Role of γ interferon and tumor necrosis factor in early resistance to murine salmonellosis, p. 255-264. In F. Cabello, C. E. Hormaeche, L. Bonina, and P. Mastroeni (ed.), Biology of Salmonella. NATO A. S. I. series A245. Plenum Press, New York, N.Y.
26. Nauciel, C., F. Espinasse-Maes, and P. Matsiota-Bernad. 1992. Role of gamma interferon and tumor necrosis factor alpha in resistance to Salmonella typhimurium infection. Infect. Immun. 60:450-454.
27. Neumann, B., A. Luz, K. Pfeffer, and B. Holzmann. 1996. Defective Peyer's patch organogenesis in mice lacking the 55-kD receptor for tumour necrosis factor. J. Exp. Med. 184:259-264.
28. Nicola, N. A. (ed.). 1995. Guidebook to cytokines and their receptors. Oxford University Press, Oxford, United Kingdom.
29. O'Brien, A. D., and E. S. Metcalf. 1982. Control of early Salmonella lyphimurium growth in innately salmonella resistant mice does not require functional T-lymphocytes. J. Immunol. 129:1349-1351.
30. O'Callaghan, D., D. Maskell, F. Y. Liew, C. S. F. Easmon, and G. Dougan. 1988. Characterization of aromatic- and purine-dependent Salmonella typhimurium: attenuation, persistence, and ability to induce protective immunity in BALB/c mice. Infect. Immun. 56:419-423.
31. O'Callaghan, D., D. Maskell, J. Tite, and G. Dougan. 1990. Immune responses in BALB/c mice following immunisation with aromatic compound or purine dependent Salmonella typhimurium strains. Immunology 69:184-189.
32. Oswald, I. P., T. A. Wynn, A. Sher, and S. L. James. 1992. IL-10 inhibits macrophage microbicidal activity by blocking the production of TNFα required as a costimulatory factor for interferon-γ induced activation. Proc. Natl. Acad. Sci. USA 89:8676-8680.
33. Pasparakis, M., L. Alexopolou, M. Grell, K. Pfizenmaier, H. Bluethmann, and G. Kollias. 1997. Peyer's patch organogenesis is intact yet formation of B lymphocyte follicles is defective in peripheral lymphoid organs of mice deficient for tumor necrosis factor and its 55-kDa receptor. Proc. Natl. Acad. Sci. USA 94:6319-6323.
34. Pie, S., P. Matsiota-Bernard, P. Truffa-Bachi, and C. Nauciel. 1996. Gamma interferon and interleukin-10 gene expression in innately susceptible and resistant mice during the early phase of Salmonella typhimurium infection. Infect. Immun. 64:849-854.
35. Plant, J., and A. A. Glynn. 1979. Locating salmonella resistance genes on mouse chromosome 1. Clin. Exp. Immunol. 37:1-6.
36. Rockett, K. A., M. M. Awburn, W. B. Cowden, and I. A. Clark. 1991. Killing of Plasmodium falciparum in vitro by nitric oxide derivatives. Infect. Immun. 59:3280-3283.
37. Rothe, J., W. Lesslauer, H. Lotscher, Y. Lang, P. Koebel, F. Kontgen, A. Althage, R. Zinkernagel, M. Steinmetz, and H. Bluethmann. 1993. Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 364:798-802.
38. Tite, J. P., G. Dougan, and S. N. Chatfield. 1991. The involvement of tumour necrosis factor in immunity to Salmonella typhimurium. J. Immunol. 47:3161-3164.
39. Tracey, K. J., and A. Cerami. 1989. Cachectin/tumour necrosis factor and other cytokines in infectious disease. Curr. Opin. Immunol. 1:454-461.
40. Vancott, J. L., M. Yamamoto, F. W. van Ginkel, N. Okahashi, D. W. Pascual. H. Kiyono, H. Bluthman, and J. R. McGhee. 1995. The host response to vaccines in the context of transgenic or targeted gene knockout mice. Mucosal Immunol. Update 3(4):3,12-14.
41. Villareal, B., P. Mastroeni, R. DeMarco de Hormaeche, and C. L. Hormaeche. 1992. Proliferative and T-cell specific IL-2/IL-4 responses in spleen cells from mice vaccinated with aroA live attenuated Salmonella vaccines. Microb. Pathog. 13:305-315.